Webinars

Hear from our team of experts that are helping our customers pursue the opportunities of this compelling therapeutic strategy by leveraging our deep NAb assay…

As therapeutic modalities have become more complex, such as cell and gene therapies, so too have the bioanalytical methods become more complex for characterizing these…

In association with Bioanalysis Zone, BioAgilytix’s Chief Scientific Officer provides an overview of their support for immuno-oncology programs, addressing pharmacokinetics, immunogenicity and biomarker assays. Watch…

As drug modalities evolve in complexity with multiplexed mechanisms of action, the need for frequent sampling of patients to monitor the safety and efficacy becomes…

Oncolytic viruses for the treatment of cancer and genetic disease has been an area of active study for decades. Testing strategies for monitoring efficacy and…

PK assays are a vital component of the drug development process and the data derived is utilized to help select the dosage for preclinical and…

Advanced modalities do not easily lend themselves to the standard approaches for quantitating drug product as small and large molecule therapeutics do. Watch Now

Technology platforms not typically used for regulated bioanalysis are now utilized more frequently to support cell and gene therapy programs. Flow cytometry, ELISpot and quantitative…

In association with Oxford Global, this webinar will highlight how to properly structure your program and get an in-depth look at the critical parameters needed…

The emergence of advanced therapeutic medicinal products (ATMPs), such as cell and gene therapies, has led to the increased utilization of specialized technology platforms in…